Average rating : HIGH
Nebula Genomics will leverage blockchain technology to eliminate the middleman and empower people to own their personal genomic data.
|Private-sale:||ENDED||0 / 0 raised|
|Pre-sale:||-||ENDED||$0/ $0 raised|
|Crowd-sale:||TBA||NOT STARTED||$0/ $0 raised|
Raised: $ 0 of $ 0 ( 0%)
|Ticker:||Available for token sale:||%|
|Token type:||ERC20||Private-sale/pre-sale token price:||no info / no info|
|Accepts:||Private-sale/pre-sale bonus:||no info/ no info|
|Prototype:||Pre-sale min/max personal cap:|
|Team:||5 persons||Crowd-sale token price:|
|Team residence:||Crowd-sale min/max personal cap:|
|Company residence:||Cant participate:|
1. A very competent gene sequencing company called `veritas` is the parent company.
2. It provides genetic sequencing services rather than simple genetic testing services. It is recognized that it is promising market, and it can be said that there are almost no rivals on ICO market.
3. Team is strong and institutional investors who are solid. Advisors, especially George Church, are prominent.
A complementary point
1. There are strong market competitors including 23andme.
2. There are not many developers yet, and they are showing weakness in marketing. Active marketing is especially important in the coin market.
3. No code has been published yet, and no tokensale has been published.see more